This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2009 Dec;54(6):465-7.

doi: 10.1097/FJC.0b013e3181c37ddc.

Rapid aldosterone signaling and vascular reactivity: relax or don't do it

Jane A Leopold¹

Affiliations

PMID: 19858736
PMCID: PMC2797578
DOI: 10.1097/FJC.0b013e3181c37ddc

Comment

Rapid aldosterone signaling and vascular reactivity: relax or don't do it

Jane A Leopold. J Cardiovasc Pharmacol. 2009 Dec.

. 2009 Dec;54(6):465-7.

doi: 10.1097/FJC.0b013e3181c37ddc.

Author

Jane A Leopold¹

Affiliation

¹ Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. jleopold@partners.org

PMID: 19858736
PMCID: PMC2797578
DOI: 10.1097/FJC.0b013e3181c37ddc

No abstract available

PubMed Disclaimer

Comment on

Nitric oxide-mediated dilation of arterioles to intraluminal administration of aldosterone.
Heylen E, Huang A, Sun D, Kaley G. Heylen E, et al. J Cardiovasc Pharmacol. 2009 Dec;54(6):535-42. doi: 10.1097/FJC.0b013e3181bfb00d. J Cardiovasc Pharmacol. 2009. PMID: 19770672 Free PMC article.

Similar articles

Sensitivity of NOS-dependent vascular relaxation pathway to mineralocorticoid receptor blockade in caveolin-1-deficient mice.
Pojoga LH, Adamová Z, Kumar A, Stennett AK, Romero JR, Adler GK, Williams GH, Khalil RA. Pojoga LH, et al. Am J Physiol Heart Circ Physiol. 2010 Jun;298(6):H1776-88. doi: 10.1152/ajpheart.00661.2009. Epub 2010 Apr 2. Am J Physiol Heart Circ Physiol. 2010. PMID: 20363891 Free PMC article.
Vascular effects of aldosterone: sorting out the receptors and the ligands.
Feldman RD, Gros R. Feldman RD, et al. Clin Exp Pharmacol Physiol. 2013 Dec;40(12):916-21. doi: 10.1111/1440-1681.12157. Clin Exp Pharmacol Physiol. 2013. PMID: 23902478 Review.
Rapid non-genomic effects of aldosterone on rodent vascular function.
Uhrenholt TR, Schjerning J, Rasmussen LE, Hansen PB, Nørregaard R, Jensen BL, Skøtt O. Uhrenholt TR, et al. Acta Physiol Scand. 2004 Aug;181(4):415-9. doi: 10.1111/j.1365-201X.2004.01313.x. Acta Physiol Scand. 2004. PMID: 15283753 Review.
Histamine-dependent prolongation by aldosterone of vasoconstriction in isolated small mesenteric arteries of the mouse.
Schjerning J, Uhrenholt TR, Svenningsen P, Vanhoutte PM, Skøtt O, Jensen BL, Hansen PB. Schjerning J, et al. Am J Physiol Heart Circ Physiol. 2013 Apr 15;304(8):H1094-102. doi: 10.1152/ajpheart.00524.2012. Epub 2013 Feb 8. Am J Physiol Heart Circ Physiol. 2013. PMID: 23396453
Nitric oxide and the proliferation of vascular smooth muscle cells.
Jeremy JY, Rowe D, Emsley AM, Newby AC. Jeremy JY, et al. Cardiovasc Res. 1999 Aug 15;43(3):580-94. doi: 10.1016/s0008-6363(99)00171-6. Cardiovasc Res. 1999. PMID: 10690330 Review. No abstract available.

See all similar articles

Cited by

Direct contribution of vascular mineralocorticoid receptors to blood pressure regulation.
Barrett KV, McCurley AT, Jaffe IZ. Barrett KV, et al. Clin Exp Pharmacol Physiol. 2013 Dec;40(12):902-9. doi: 10.1111/1440-1681.12125. Clin Exp Pharmacol Physiol. 2013. PMID: 23710823 Free PMC article. Review.
Diabetes impairs the vascular effects of aldosterone mediated by G protein-coupled estrogen receptor activation.
Ferreira NS, Cau SB, Silva MA, Manzato CP, Mestriner FL, Matsumoto T, Carneiro FS, Tostes RC. Ferreira NS, et al. Front Pharmacol. 2015 Mar 2;6:34. doi: 10.3389/fphar.2015.00034. eCollection 2015. Front Pharmacol. 2015. PMID: 25784875 Free PMC article.
Mineralocorticoid receptors in vascular function and disease.
McCurley A, Jaffe IZ. McCurley A, et al. Mol Cell Endocrinol. 2012 Mar 24;350(2):256-65. doi: 10.1016/j.mce.2011.06.014. Epub 2011 Jun 24. Mol Cell Endocrinol. 2012. PMID: 21723914 Free PMC article. Review.
Smooth muscle cell mineralocorticoid receptors: role in vascular function and contribution to cardiovascular disease.
McCurley A, McGraw A, Pruthi D, Jaffe IZ. McCurley A, et al. Pflugers Arch. 2013 Dec;465(12):1661-70. doi: 10.1007/s00424-013-1282-4. Epub 2013 May 1. Pflugers Arch. 2013. PMID: 23636772 Free PMC article. Review.

References

1. Booth RE, Johnson JP, Stockand JD. Aldosterone. Adv Physiol Educ. 2002;26:8–20. - PubMed
1. Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, Bittman R, Hurley S, Kleiman J, Gatlin M. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 2003;348:1309–1321. - PubMed
1. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med. 1999;341:709–717. - PubMed
1. Struthers AD. Impact of aldosterone on vascular pathophysiology. Congest Heart Fail. 2002;8:18–22. - PubMed
1. Farquharson CA, Struthers AD. Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin I/angiotensin II conversion in patients with chronic heart failure. Circulation. 2000;101:594–597. - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources